A legacy Research Base serving the CCOP program since 1983, transitioning into NCORP, the University of Rochester (URCC) proposes to continue its research focus on decreasing physical and psychological treatment-related morbidity and mortality among cancer patients, survivors, and their care partners by improving the quality of cancer care that addresses toxicities and side effects stemming from the cancer experience. Over the past 30 years the URCC has evolved and developed considerable resources for cancer control and cancer care delivery research activities. The 4,871 credits earned during the last five-year renewal period by Research Base affiliates on URCC protocols are 22% of the total cancer control credits provided for the 14 research bases funded during that period, according to NCI CCOP Program Staff. Over the next five years, the Research Base will continue its commitment as a university-based NCORP Research Base, producing state-of-the-science cancer control and cancer care delivery research. Our process and organization fosters protocol development through close collaboration among community affiliates and experienced investigators;data collected through our clinical and observational trials informs future research and policy;we pioneer use of new methodologies and exploration of mechanistic pathways;and we are dedicated to increasing the diversity of participants in our trials and to training junior investigators and community affiliates. Fifty-seven different potential research concepts have been presented and discussed in open forum at the last five annual group meetings. Twenty-one of them were proposed by colleagues geographically outside the University including eight from community affiliates. Each of the current eight approved protocols is either chaired or co-chaired by current CCOP/MBCCOP community affiliates.
Symptoms and side effects of cancer and its treatment can significantly affect patients'well-being and are frequently dose-limiting factors in potentially curative treatments. Dr. Harold Varmus recognized the relevance and benefits of their control when he said Cancer Patients are living longer and better lives, thanks to better symptom control, more effective therapies, and a deeper understanding of cancer.
|Mohile, Supriya G; Magnuson, Allison; Pandya, Chintan et al. (2018) Community Oncologists' Decision-Making for Treatment of Older Patients With Cancer. J Natl Compr Canc Netw 16:301-309|
|Loh, Kah Poh; McHugh, Colin; Mohile, Supriya G et al. (2018) Using Information Technology in the Assessment and Monitoring of Geriatric Oncology Patients. Curr Oncol Rep 20:25|
|Lin, Po-Ju; Peppone, Luke J; Janelsins, Michelle C et al. (2018) Yoga for the Management of Cancer Treatment-Related Toxicities. Curr Oncol Rep 20:5|
|Cathcart-Rake, Elizabeth J; Zemla, Tyler; Jatoi, Aminah et al. (2018) Acquisition of sexual orientation and gender identity data among NCI Community Oncology Research Program practice groups. Cancer :|
|Ryan Wolf, Julie; Heckler, Charles E; Guido, Joseph J et al. (2018) Oral curcumin for radiation dermatitis: a URCC NCORP study of 686 breast cancer patients. Support Care Cancer 26:1543-1552|
|Magnuson, Allison; Lemelman, Tatyana; Pandya, Chintan et al. (2018) Geriatric assessment with management intervention in older adults with cancer: a randomized pilot study. Support Care Cancer 26:605-613|
|Flannery, Marie; Stein, Karen F; Dougherty, David W et al. (2018) Nurse-Delivered Symptom Assessment for Individuals With Advanced Lung Cancer. Oncol Nurs Forum 45:619-630|
|Mohile, Supriya G; Dale, William; Somerfield, Mark R et al. (2018) Practical Assessment and Management of Vulnerabilities in Older Patients Receiving Chemotherapy: ASCO Guideline for Geriatric Oncology Summary. J Oncol Pract 14:442-446|
|Kleckner, Ian R; Dunne, Richard F; Asare, Matthew et al. (2018) Exercise for Toxicity Management in Cancer-A Narrative Review. Oncol Hematol Rev 14:28-37|
|Ramsdale, Erika; Lemelman, Tatyana; Loh, Kah Poh et al. (2018) Geriatric assessment-driven polypharmacy discussions between oncologists, older patients, and their caregivers. J Geriatr Oncol 9:534-539|
Showing the most recent 10 out of 106 publications